Treatment of Na2PdCl4 or [MCl2(PhCN)2] with bis(4-pyridyl)diselenide yielded an insoluble product of composition [MCl2(4,4′-(C5H4N)2Se2)]n (1). The reactions of Na2PdCl4 with one and two eq. of Na(4-SeC5H4N) afforded insoluble products [PdCl(4-SeC5H4N)]n (2) and [Pd(4-SeC5H4N)2]n (3), respectively. On treatment with PPh3, 2 and 3 gave trans-[PdCl(4-SeC5H4N)(PPh3)2] (4a) and trans-[Pd(4-SeC5H4N)2(PPh3)2] (5a), respectively. The oxidative addition of bis(4-pyridyl)diselenide to Pt(PPh3)4 exclusively yielded trans-[Pt(4-SeC5H4N)2(PPh3)2] (5b). The treatment of two eq. of Na(4-SeC5H4N) with cis-[PtX2(PR3)2] afforded 5b (X = Cl) and trans-[Pt(4-SeC5H4N)2(PEt3)2] (5c) (X = Cl or CF3SO3). The reactions of cis-[MCl2(P∩P)] and [M2Cl2(μ-Cl)2(PR3)2] with two eq. of Na(4-SeC5H4N) exclusively yielded cis-[M(4-SeC5H4N)2(P∩P)] (M/P∩P = Pd/dppe (6a), Pt/dppm (6b) and Pt/dppp (6c)) and [MCl(4-SeC5H4N)(PR3)]n (7), respectively. The complex trans-[PtCl(4-SeC5H4N)(PEt3)2] (4b) was isolated from the redistribution reaction between 5c and cis-[PtCl2(PEt3)2]. The complex [PdCl(4-SeC5H4N)(PPh3)]n (7b) exists in bi- and tri-nuclear forms, whereas [MCl(4-SeC5H4N)(PEt3)]n (7a, 7c) and [PtCl(4-SeC5H4N)(PMe2Ph)]n (7d) retain their trinuclear structure in solution. Molecular structures of 4a, 4b, 5a, 5c, 6a, 6c, 7a, 7b and 7c were established by single crystal X-ray diffraction analyses. The complexes trans-[PdCl(4-SeC5H4N)(PPh3)2] and [PdCl(4-SeC5H4N)(PPh3)]n can act as catalysts for Suzuki C–C cross coupling reaction.
A series of 2-(3,5-dimethylpyrazol-1-yl)ethylseleno derivatives has been synthesized. The glutathione peroxidase like catalytic activity of these compounds has been studied in a model system, in which reduction of hydrogen peroxide with dithiothreitol (DTT(red)), in the presence of an organoselenium compound was investigated by (1)H NMR spectroscopy. All these compounds exhibit GPx like catalytic activities and the catalytic reaction proceeds through a selenoxide intermediate, identified by (77)Se{(1)H} NMR spectroscopy.
The complexes [Pd(μ-ER)(η3-allyl)]2 (ER = EMes; E = S, Se; allyl = C3H5, C4H7) have been isolated by the reaction of [Pb(ER)2]
n
with [Pd2(μ-Cl)2(η3-allyl)2]. Similar reactions with [Pb(SeCH2CH2NMe2)2]
n
resulted in the formation of a trinuclear complex [Pd3Cl2(κ2-Se,N-SeCH2CH2NMe2)(η3-allyl)3]. Treatment of [Pd(μ-SR)(η3-C4H7)]2 with [Pd(SMes)2]
n
in 1:1 ratio yielded [Pd3(μ-SMes)4(η3-C4H7)2]. These complexes were characterized by elemental analyses and mass, UV−vis, and NMR spectroscopy. The structures of [Pd2(μ-EMes)2(η3-C4H7)2] (E = S, Se) were established by single-crystal X-ray diffraction analysis, which revealed a syn configuration. Two new structural motifs for [Pd3Cl2(κ2-Se,N-SeCH2CH2NMe2)(η3-C3H5)3] and [Pd3(μ-SMes)4(η3-C4H7)2] have also been identified. Pyrolysis of [Pd(μ-ER)(η3-C4H7)]2 yielded palladium chalcogenides, which were characterized by powder XRD and EDAX.
The complexes, [Cu{EC(5)H(3)(R-3)N}](4) (E/R = Se/Me or Te/R; R = H or Me) were isolated by the reaction between CuCl and NaEC(5)H(3)(R-3)N and were characterized by elemental analyses, uv-vis and NMR ((1)H, (13)C) spectroscopy. The crystal structures of [Cu{SeC(5)H(3)(Me-3)N}](4) and [Cu(TeC(5)H(4)N)](4) revealed that the molecules are tetrameric in which each copper atom lies at the vertex of the tetrahedron and each face of the tetrahedron is capped by the bridging pyridylchalcogenolate ligand. Thermal behavior of these complexes was studied by thermogravimetric analysis. Depending on reaction conditions, thermolysis gave both stoichiometric and non-stoichiometric copper chalcogenides, which were characterized by XRD, EDX, SEM, TEM and SAED techniques. These precursors were used for the preparation of nanocrystals and for deposition of thin films of copper chalcogenides by AACVD (Aerosol Assisted Chemical Vapor Deposition).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.